Inventor
LANZA ROBERT P
US35 patents
⚠️ This page may combine multiple inventors who share the name “LANZA ROBERT P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ASTELLAS INST FOR REGENERATIVE MEDICINE
17 patentsUS10894065B2Jan 19, 2021
Methods for production of platelets from pluripotent stem cells and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE9 citations94
US10307444B2Jun 4, 2019
Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
ASTELLAS INST FOR REGENERATIVE MEDICINE19 citations94
US9993503B2Jun 12, 2018
Methods for production of platelets from pluripotent stem cells and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE17 citations94
US9650607B2May 16, 2017
Modalities for the treatment of degenerative diseases of the retina
ASTELLAS INST FOR REGENERATIVE MEDICINE10 citations92
US11241460B2Feb 8, 2022
Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
ASTELLAS INST FOR REGENERATIVE MEDICINE8 citations86
US11400118B2Aug 2, 2022
Methods for production of platelets from pluripotent stem cells and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE5 citations84
US9752118B2Sep 5, 2017
Method of directed differentiation producing corneal endothelial cells from neural crest stem cells by PDGFB and DKK2, compositions thereof, and uses thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE8 citations82
US12109239B2Oct 8, 2024
Methods for production of human hemogenic endothelial cells from pluripotent stem cells and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE1 citations73
US12076347B2Sep 3, 2024
Methods for production of platelets from pluripotent stem cells and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE1 citations73
US10584313B2Mar 10, 2020
Method of producing a differentiated mammalian cell comprising culturing a single mammalian blastomere
ASTELLAS INST FOR REGENERATIVE MEDICINE3 citations72
US10072243B2Sep 11, 2018
Derivation of embryonic stem cells and embryo-derived cells
ASTELLAS INST FOR REGENERATIVE MEDICINE3 citations72
US12097223B2Sep 24, 2024
Mesenchymal stromal cells and uses related thereto
ASTELLAS INST FOR REGENERATIVE MEDICINE2 citations69
US12558380B2Feb 24, 2026
Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
ASTELLAS INST FOR REGENERATIVE MEDICINE0 citations62
US12508284B2Dec 30, 2025
Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells
ASTELLAS INST FOR REGENERATIVE MEDICINE0 citations62
US12049642B2Jul 30, 2024
Corneal endothelial cells with increased cell density and compositions thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE1 citations60
US12465621B2Nov 11, 2025
Mesenchymal stromal cells and uses related thereto
ASTELLAS INST FOR REGENERATIVE MEDICINE0 citations59
US12209255B2Jan 28, 2025
Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
ASTELLAS INST FOR REGENERATIVE MEDICINE0 citations57
OCATA THERAPEUTICS INC
7 patentsUS9040039B2May 26, 2015
Modalities for the treatment of degenerative diseases of the retina
OCATA THERAPEUTICS INC23 citations96
US10426799B2Oct 1, 2019
Methods for production of platelets from pluripotent stem cells and compositions thereof
OCATA THERAPEUTICS INC13 citations92
US9730962B2Aug 15, 2017
Modalities for the treatment of degenerative diseases of the retina
OCATA THERAPEUTICS INC17 citations92
US9193950B2Nov 24, 2015
Modalities for the treatment of degenerative diseases of the retina
OCATA THERAPEUTICS INC16 citations92
US9181524B2Nov 10, 2015
Modalities for the treatment of degenerative diseases of the retina
OCATA THERAPEUTICS INC16 citations92
US9040038B2May 26, 2015
Modalities for the treatment of degenerative diseases of the retina
OCATA THERAPEUTICS INC17 citations92
US9617512B2Apr 11, 2017
Derivation of embryonic stem cells and embryo-derived cells
OCATA THERAPEUTICS INC4 citations83
BIOHYBRID TECH INC
3 patentsUS5891477AApr 6, 1999
Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device
BIOHYBRID TECH INC59 citations95
US5912005AJun 15, 1999
Methods of use of uncoated gel particles
BIOHYBRID TECH INC83 citations94
US5651980AJul 29, 1997
Methods of use of uncoated gel particles
BIOHYBRID TECH INC40 citations90
ADVANCED CELL TECH INC
3 patentsUS9763984B2Sep 19, 2017
Methods for production of platelets from pluripotent stem cells and compositions thereof
ADVANCED CELL TECH INC15 citations92
US9045732B2Jun 2, 2015
Modalities for the treatment of degenerative diseases of the retina
ADVANCED CELL TECH INC18 citations92
US9550974B2Jan 24, 2017
Derivation of embryonic stem cells
ADVANCED CELL TECH INC4 citations72
KLIMANSKAYA IRINA V
2 patentsUS8268303B2Sep 18, 2012
Methods for producing enriched populations of human retinal pigment epithelium cells for treatment of retinal degeneration
KLIMANSKAYA IRINA V31 citations95
US9649340B2May 16, 2017
Methods for producing enriched populations of human retinal pigment epithelium cells
KLIMANSKAYA IRINA V10 citations92